The present study, therefore, aims to investigate the potential role of the miRNAs miR-138, -210 and -335 and their downstream effector, HIF-1α and MMP9, as well as changes induced by sevoflurane or desflurane, which are commonly used clinically on ovarian cancer cell biology and malignancy. Here, MMP9 is linked to ovarian cancer.